HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast

In this episode, we discuss three "older" antihypertensives that are not preferred first-line therapies: clonidine, methyldopa, and minoxidil.  We outline why these agents are not first-line therapies and review their pharmacology and adverse effect profiles.

Direct download: 065_-_Old_HTN_drugs.mp3
Category:general -- posted at: 6:00am EDT

In this episode, we discuss the history of ergot products for treatment of migraines. We compare their safety and efficacy to newer agents such as the triptans and assess their resultant place in therapy.

Direct download: 064_-_Ergots.mp3
Category:general -- posted at: 6:00am EDT

In this episode, we discuss several aspects of serotonin syndrome including the typical clinical presentation, its etiology and common drug-induced combinations, and how to appropriately manage the syndrome.

Direct download: 063_-_Serotonin_syndrome.mp3
Category:general -- posted at: 6:00am EDT

In this episode, we discuss the pathophysiology of embolic stroke in patients with atrial fibrillation and review the use of left atrial occlusion devices, such as the WATCHMAN device, to reduce the risk of stroke in patients with atrial fibrillation without the use of anticoagulants like warfarin.

Direct download: 062_-_LAA_onclusion.mp3
Category:general -- posted at: 6:00am EDT

In this episode, we review the 12 recommendations from the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain.  These recommendations are intended to help curb the opioid epidemic and provide guidance to healthcare providers regarding safer use o

Direct download: 061_-_CDC_opioid_guidelines.mp3
Category:general -- posted at: 6:00am EDT

In this episode, we discuss the concept of professional advocacy, with a particular focus on how to advocate for the profession of pharmacy and what tools and organizations are available to assist in being an advocate.

Direct download: 060_-_Pharmacy_advocacy.mp3
Category:general -- posted at: 6:00am EDT

In this episode, we discuss with Dr. Megan Hartranft the five oncology drugs that every pharmacist should know about, which is a great review for P4 students who are currently preparing for the NAPLEX.  We cover cyclophosphamide, cisplatin, methotrexate, doxorubicin, and vincristine.

Direct download: 059_-_Top_5_Oncology_Drugs.mp3
Category:general -- posted at: 6:00am EDT

In this episode, we discuss the newest definition of sepsis and septic shock according to the Sepsis-3 criteria and the 2016 Surviving Sepsis guidelines.  We also review the scoring systems of “qSOFA” and “SOFA” and use a patient case to help demonstrate the new definitions.

Direct download: 058_-_Sepsis-3.mp3
Category:general -- posted at: 6:00am EDT

In this episode, we discuss the overuse of proton pump inhibitor (PPI) therapy and several concerns regarding chronic use of this medication class, including hypomagnesemia, fracture risk, low seurm B12 levels, anemias, and increased risk of certain infections.

Direct download: 057_-_PPI_overuse.mp3
Category:general -- posted at: 6:00am EDT

In this episode, we discuss the new FDA categorizations of biosimilars, the legal implications of biologic/biosimilar prescriptions, and the new "follow-on" approval pathway of Basaglar, a new insulin glargine U-100 product.

Direct download: 056_-_Biosimilars.mp3
Category:general -- posted at: 6:00am EDT